Illumen Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Illumen Therapeutics General Information
Description
Developer of cancer treatment drugs designed to address the root cause of many cancers by restoring the body's natural defense mechanisms. The company focuses on inhibiting a specific enzyme, PARN (Poly(A)-specific ribonuclease), to increase the function of the tumor suppressor protein, enabling researchers to develop new treatment options for aggressive cancer types.
Contact Information
Website
www.IllumenTx.comCorporate Office
- 4845 Pearl East Circle
- Suite 118 PMB 58457
- Boulder, CO 80301
- United States
Corporate Office
- 4845 Pearl East Circle
- Suite 118 PMB 58457
- Boulder, CO 80301
- United States
Illumen Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 18-Mar-2025 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup | |||
| 1. Spin-Off | Completed | Startup |
Illumen Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Venture Partners at CU Boulder | Accelerator/Incubator | |||
| National Science Foundation Innovation Corps Program | Accelerator/Incubator | |||
| University of Colorado, Boulder | Corporation | Minority |
Illumen Therapeutics FAQs
-
When was Illumen Therapeutics founded?
Illumen Therapeutics was founded in 2024.
-
Where is Illumen Therapeutics headquartered?
Illumen Therapeutics is headquartered in Boulder, CO.
-
What industry is Illumen Therapeutics in?
Illumen Therapeutics’s primary industry is Drug Discovery.
-
Is Illumen Therapeutics a private or public company?
Illumen Therapeutics is a Private company.
-
What is Illumen Therapeutics’s current revenue?
The current revenue for Illumen Therapeutics is .
-
Who are Illumen Therapeutics’s investors?
Venture Partners at CU Boulder, National Science Foundation Innovation Corps Program, and University of Colorado, Boulder have invested in Illumen Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process